Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
株式のランク #12697
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
株価
$2.04
時価総額
$122.58M
変化(1日)
4.48%
変化(1年)
-1.05%
FR
取引 Crossject Société Anonyme (ALCJ)

カテゴリー

Crossject Société Anonyme(ALCJ)の発行済株式数
December 2025 時点の発行済株式数 52.26M
Crossject Société Anonyme の最新の財務報告および株価によると、現在の発行済株式数は 52.26M です。December 2023 の終わりには、同社は 37.09M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Crossject Société Anonyme(ALCJ)の発行済株式数の履歴(2010 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 52.26M 15.51%
2024 45.24M 21.99%
2023 37.09M 2.00%
2022 36.36M 39.81%
2021 26.01M 8.11%
2020 24.06M 19.51%
2019 20.13M 47.92%
2018 13.61M 47.92%
2017 9.20M 21.62%
2016 7.56M 7.89%
2015 7.01M 5.42%
2014 6.65M 25.86%
2013 5.28M 19.22%
2012 4.43M 0.00%
2011 4.43M 0.00%
2010 4.43M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数
354.90M 579.08%
US
463.21M 786.33%
FR
345.26M 560.64%
DE
336.65M 544.17%
JP
280.64M 436.99%
US